Global ePharmacy Market – Industry Trends and Forecast to 2031
Report ID: MS-1491 | Healthcare and Pharma | Last updated: Jul, 2024 | Formats*:
Description
Table of content
Market Segments
The ePharmacy market is experiencing robust expansion, with market size projected to increase from XX billion in 2024 to
xx billion by 2031, demonstrating a consistent year-over-year growth rate of 15.1%. ePharmacy Market Size, Share, Competitive Landscape and Trend Analysis Report, by Types (Over the Counter Product, Prescription Medicines), And regions (North America(United States.Canada.Mexico), South America(Brazil.Argentina.Chile.Rest of South America), Europe(Germany.France.Italy.United Kingdom.Benelux.Nordics.Rest of Europe), Asia Pacific(China.Japan.India.South Korea.Australia.Southeast Asia.Rest of Asia-Pacific), MEA(Middle East.Africa)) : Industry Forecast and Opportunity Analysis for 2024 - 2031
The ePharmacy market represents a selling platform for prescription and over-the-counter medications via online media, together with healthcare products and, at times, medical services. The term simply means a digital format of traditional pharmacies. This marketplace provides ease and convenience by allowing customers to browse and order medications from the comfort of their homes, mainly with additional features like prescription refills and doorstep delivery.
It provides impetus to the e-pharmacy market, among others. Internet and smartphone penetration helps to increase comfort with online transactions, thereby gliding access to digital technologies and causing a surge in e-pharmacies.
ePharmacy Report Highlights
Report Metrics | Details |
---|---|
Forecast period | 2019-2031 |
Base Year Of Estimation | 2023 |
Growth Rate | CAGR of 15.1% |
By Product Type | Over the Counter Product, Prescription Medicines |
Key Market Players |
|
By Region |
|
ePharmacy Market Leading Players
The key players profiled in the report are Amazon. Inc, Apotek, CVS Health, Doc Morris, Express Scripts, Giant Eagle .Inc., L Rowland & Co (Retail) Ltd, McKesson Corporation, Medlife, Netmeds Marketplace Ltd., Optum. Inc., SHOP-APOTHEKE EUROPE N.V., T Easy Medico, The Kroger Co., UK Meds Direct Ltd., Walgreen Co., Walgreens Boots Alliance. Inc., Walmart, Zur Rose Group AGGrowth Accelerators
Backed by multiple strong forces, the playing field of the ePharmacy market has been acting growth-conducive. Increasing Internet & Smartphone Penetration: The trend for using the internet and, hence, the use of smartphones for accessing the former is increasing across the globe. With increasing comfort in online transactions, ePharmacy gets a kick-start as one can easily research medications on their devices, price compare across various ePharmacies, and refill prescriptions, thus circumventing the need to visit a store. Growing Demand for Convenience: The ePharmacy market caters to convenience in managing healthcare needs. The value-added services provided by these online pharmacies, including door-to-door delivery of medications, automatic refills, and online consultation with pharmacists, save much time and effort for consumers compared to traditional pharmacies. This is particularly attractive to those in busy groups, patients who become chronically ill and need several medications, and people living in remote areas where access to a physical pharmacy is limited.ePharmacy Market Segmentation analysis
The Global ePharmacy is segmented by Type, and Region. By Type, the market is divided into Distributed Over the Counter Product, Prescription Medicines . Geographically, the market is assessed across key Regions like North America(United States.Canada.Mexico), South America(Brazil.Argentina.Chile.Rest of South America), Europe(Germany.France.Italy.United Kingdom.Benelux.Nordics.Rest of Europe), Asia Pacific(China.Japan.India.South Korea.Australia.Southeast Asia.Rest of Asia-Pacific), MEA(Middle East.Africa) and others, each presenting distinct growth opportunities and challenges influenced by the regions.Competitive Landscape
The electronic pharmacy market is moderately competitive, characterised by a blend of incumbents and new entrants. Brick and Mortar Pharmacies versus Online Players on the Ground: The offline, existing pharmacy chains use their name and reach through physical stores to build a strong online presence. They are then able to offer in-store pickup, a convenient hybrid model for the customer. They put pressure on online-only ePharmacies to differentiate themselves based on the points of a wider selection of products, competitive pricing, and better customer service. Competition for convenience and price: This is one battleground where players competing in the ePharmacy market have to raise the stake from levels of the order processing speed, delivery timelines, mobile app functionalities, and support for reordering refills of prescriptions. In addition, competitiveness in pricing stays critical, as besides discounts, ePharmacies offer loyalty programmes and insurance integrations to attract customers.Challenges In ePharmacy Market
Despite the convenience associated with and potential growth of the e-pharmacy market, there exist far-reaching challenges to its further adoption and smooth running. Two key areas of concern in this direction include: Regulatory: There are several concerns regarding legitimacy. Since e-pharmacies deal with prescription medications, there is the foremost concern of patient safety and adherence to the regulations. The strict regulation hovering above the online prescription verification, storage, and transportation of medication, and data privacy add complexities to the businesses of ePharmacies. Not only this, but some consumers also show scepticism regarding the legitimacy of an online pharmacy, mostly with sourcing genuine medications, their quality control, and maintenance. Generation and retention of trust and relationships with patients: ePharmacies must build trust from patients who are accustomed to personal contact with a pharmacist. Patients might be wary of sending questions or seeking consultation via the Internet because no consultations are conducted in person. Secondly, more effort is needed on the part of ePharmacies to establish good relationships with patients in order to improve adherence and proper use of medication, which are more easily achieved in a physical pharmacy.Key Target Audience
It is for this wide audience, driven by convenience, affordability, and probably extended choice of health options, that the ePharmacy market has strategically targeted:,, Tech-Savvy Consumers: This group of consumers is comfortable working online and appreciates the convenience ePharmacies provide. They can view medication options, refill their medications, and schedule them to be delivered directly to one's doorstep—no visiting a pharmacy in real-time is necessary. This is especially so for the busy professional and for those managing chronic conditions where they are compelled to get their medications refilled almost monthly.,, Value-Conscious Customers: The ePharmacy market can offer very competitive pricing on medications at the best value, mostly on generic drugs. Compared to traditional pharmacies, customers can get better price deals by comparing prices between various licensed online pharmacies. Moreover, value-conscious consumers could be attracted by some ePharmacies that give loyalty programmes or discounts to customers.Merger and acquisition
It is not that easy to track specific mergers and acquisitions in the e-pharmacy market. Public M&A data is usually readily available with respect to large companies or well-established chains. What follows discusses a few of the possible scenarios for M&A activity in this market. Brick-and-Mortar Consolidation: Consolidation through mergers of the large established pharmacy chains could help in better competition with these digital-first ePharmacy startups by way of more substantial scale-up of online infrastructure and further product range for customers. Acquisitions by tech giants: Large tech companies having robust logistics and e-commerce expertise may acquire a small e-pharmacy or online pharmacy platform in the aim of having an online pharmacy presence. It could bring a great deal of technical impetus to e-pharmacies, thereby helping them in scaling their operations and reaching more customers.Table of content
1: Introduction
2: Executive Summary
3: Market Overview
4: ePharmacy Market by Type
5: ePharmacy Market by Region
7: Company Profiles
8: Analyst Perspective and Conclusion
- 1.1 Report description
- 1.2 Key market segments
- 1.3 Key benefits to the stakeholders
2: Executive Summary
- 2.1 ePharmacy- Snapshot
- 2.2 ePharmacy- Segment Snapshot
- 2.3 ePharmacy- Competitive Landscape Snapshot
3: Market Overview
- 3.1 Market definition and scope
- 3.2 Key findings
- 3.2.1 Top impacting factors
- 3.2.2 Top investment pockets
- 3.3 Porter’s five forces analysis
- 3.3.1 Low bargaining power of suppliers
- 3.3.2 Low threat of new entrants
- 3.3.3 Low threat of substitutes
- 3.3.4 Low intensity of rivalry
- 3.3.5 Low bargaining power of buyers
- 3.4 Market dynamics
- 3.4.1 Drivers
- 3.4.2 Restraints
- 3.4.3 Opportunities
4: ePharmacy Market by Type
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Over the Counter Product
- 4.2.1 Key market trends, factors driving growth, and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3 Prescription Medicines
- 4.3.1 Key market trends, factors driving growth, and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
5: ePharmacy Market by Region
- 5.1 Overview
- 5.1.1 Market size and forecast By Region
- 5.2 North America
- 5.2.1 Key trends and opportunities
- 5.2.2 Market size and forecast, by Type
- 5.2.3 Market size and forecast, by Application
- 5.2.4 Market size and forecast, by country
- 5.2.4.1 United States
- 5.2.4.1.1 Key market trends, factors driving growth, and opportunities
- 5.2.4.1.2 Market size and forecast, by Type
- 5.2.4.1.3 Market size and forecast, by Application
- 5.2.4.2 Canada
- 5.2.4.2.1 Key market trends, factors driving growth, and opportunities
- 5.2.4.2.2 Market size and forecast, by Type
- 5.2.4.2.3 Market size and forecast, by Application
- 5.2.4.3 Mexico
- 5.2.4.3.1 Key market trends, factors driving growth, and opportunities
- 5.2.4.3.2 Market size and forecast, by Type
- 5.2.4.3.3 Market size and forecast, by Application
- 5.2.4.1 United States
- 5.3 South America
- 5.3.1 Key trends and opportunities
- 5.3.2 Market size and forecast, by Type
- 5.3.3 Market size and forecast, by Application
- 5.3.4 Market size and forecast, by country
- 5.3.4.1 Brazil
- 5.3.4.1.1 Key market trends, factors driving growth, and opportunities
- 5.3.4.1.2 Market size and forecast, by Type
- 5.3.4.1.3 Market size and forecast, by Application
- 5.3.4.2 Argentina
- 5.3.4.2.1 Key market trends, factors driving growth, and opportunities
- 5.3.4.2.2 Market size and forecast, by Type
- 5.3.4.2.3 Market size and forecast, by Application
- 5.3.4.3 Chile
- 5.3.4.3.1 Key market trends, factors driving growth, and opportunities
- 5.3.4.3.2 Market size and forecast, by Type
- 5.3.4.3.3 Market size and forecast, by Application
- 5.3.4.4 Rest of South America
- 5.3.4.4.1 Key market trends, factors driving growth, and opportunities
- 5.3.4.4.2 Market size and forecast, by Type
- 5.3.4.4.3 Market size and forecast, by Application
- 5.3.4.1 Brazil
- 5.4 Europe
- 5.4.1 Key trends and opportunities
- 5.4.2 Market size and forecast, by Type
- 5.4.3 Market size and forecast, by Application
- 5.4.4 Market size and forecast, by country
- 5.4.4.1 Germany
- 5.4.4.1.1 Key market trends, factors driving growth, and opportunities
- 5.4.4.1.2 Market size and forecast, by Type
- 5.4.4.1.3 Market size and forecast, by Application
- 5.4.4.2 France
- 5.4.4.2.1 Key market trends, factors driving growth, and opportunities
- 5.4.4.2.2 Market size and forecast, by Type
- 5.4.4.2.3 Market size and forecast, by Application
- 5.4.4.3 Italy
- 5.4.4.3.1 Key market trends, factors driving growth, and opportunities
- 5.4.4.3.2 Market size and forecast, by Type
- 5.4.4.3.3 Market size and forecast, by Application
- 5.4.4.4 United Kingdom
- 5.4.4.4.1 Key market trends, factors driving growth, and opportunities
- 5.4.4.4.2 Market size and forecast, by Type
- 5.4.4.4.3 Market size and forecast, by Application
- 5.4.4.5 Benelux
- 5.4.4.5.1 Key market trends, factors driving growth, and opportunities
- 5.4.4.5.2 Market size and forecast, by Type
- 5.4.4.5.3 Market size and forecast, by Application
- 5.4.4.6 Nordics
- 5.4.4.6.1 Key market trends, factors driving growth, and opportunities
- 5.4.4.6.2 Market size and forecast, by Type
- 5.4.4.6.3 Market size and forecast, by Application
- 5.4.4.7 Rest of Europe
- 5.4.4.7.1 Key market trends, factors driving growth, and opportunities
- 5.4.4.7.2 Market size and forecast, by Type
- 5.4.4.7.3 Market size and forecast, by Application
- 5.4.4.1 Germany
- 5.5 Asia Pacific
- 5.5.1 Key trends and opportunities
- 5.5.2 Market size and forecast, by Type
- 5.5.3 Market size and forecast, by Application
- 5.5.4 Market size and forecast, by country
- 5.5.4.1 China
- 5.5.4.1.1 Key market trends, factors driving growth, and opportunities
- 5.5.4.1.2 Market size and forecast, by Type
- 5.5.4.1.3 Market size and forecast, by Application
- 5.5.4.2 Japan
- 5.5.4.2.1 Key market trends, factors driving growth, and opportunities
- 5.5.4.2.2 Market size and forecast, by Type
- 5.5.4.2.3 Market size and forecast, by Application
- 5.5.4.3 India
- 5.5.4.3.1 Key market trends, factors driving growth, and opportunities
- 5.5.4.3.2 Market size and forecast, by Type
- 5.5.4.3.3 Market size and forecast, by Application
- 5.5.4.4 South Korea
- 5.5.4.4.1 Key market trends, factors driving growth, and opportunities
- 5.5.4.4.2 Market size and forecast, by Type
- 5.5.4.4.3 Market size and forecast, by Application
- 5.5.4.5 Australia
- 5.5.4.5.1 Key market trends, factors driving growth, and opportunities
- 5.5.4.5.2 Market size and forecast, by Type
- 5.5.4.5.3 Market size and forecast, by Application
- 5.5.4.6 Southeast Asia
- 5.5.4.6.1 Key market trends, factors driving growth, and opportunities
- 5.5.4.6.2 Market size and forecast, by Type
- 5.5.4.6.3 Market size and forecast, by Application
- 5.5.4.7 Rest of Asia-Pacific
- 5.5.4.7.1 Key market trends, factors driving growth, and opportunities
- 5.5.4.7.2 Market size and forecast, by Type
- 5.5.4.7.3 Market size and forecast, by Application
- 5.5.4.1 China
- 5.6 MEA
- 5.6.1 Key trends and opportunities
- 5.6.2 Market size and forecast, by Type
- 5.6.3 Market size and forecast, by Application
- 5.6.4 Market size and forecast, by country
- 5.6.4.1 Middle East
- 5.6.4.1.1 Key market trends, factors driving growth, and opportunities
- 5.6.4.1.2 Market size and forecast, by Type
- 5.6.4.1.3 Market size and forecast, by Application
- 5.6.4.2 Africa
- 5.6.4.2.1 Key market trends, factors driving growth, and opportunities
- 5.6.4.2.2 Market size and forecast, by Type
- 5.6.4.2.3 Market size and forecast, by Application
- 5.6.4.1 Middle East
- 6.1 Overview
- 6.2 Key Winning Strategies
- 6.3 Top 10 Players: Product Mapping
- 6.4 Competitive Analysis Dashboard
- 6.5 Market Competition Heatmap
- 6.6 Leading Player Positions, 2022
7: Company Profiles
- 7.1 Amazon. Inc
- 7.1.1 Company Overview
- 7.1.2 Key Executives
- 7.1.3 Company snapshot
- 7.1.4 Active Business Divisions
- 7.1.5 Product portfolio
- 7.1.6 Business performance
- 7.1.7 Major Strategic Initiatives and Developments
- 7.2 Apotek
- 7.2.1 Company Overview
- 7.2.2 Key Executives
- 7.2.3 Company snapshot
- 7.2.4 Active Business Divisions
- 7.2.5 Product portfolio
- 7.2.6 Business performance
- 7.2.7 Major Strategic Initiatives and Developments
- 7.3 CVS Health
- 7.3.1 Company Overview
- 7.3.2 Key Executives
- 7.3.3 Company snapshot
- 7.3.4 Active Business Divisions
- 7.3.5 Product portfolio
- 7.3.6 Business performance
- 7.3.7 Major Strategic Initiatives and Developments
- 7.4 Doc Morris
- 7.4.1 Company Overview
- 7.4.2 Key Executives
- 7.4.3 Company snapshot
- 7.4.4 Active Business Divisions
- 7.4.5 Product portfolio
- 7.4.6 Business performance
- 7.4.7 Major Strategic Initiatives and Developments
- 7.5 Express Scripts
- 7.5.1 Company Overview
- 7.5.2 Key Executives
- 7.5.3 Company snapshot
- 7.5.4 Active Business Divisions
- 7.5.5 Product portfolio
- 7.5.6 Business performance
- 7.5.7 Major Strategic Initiatives and Developments
- 7.6 Giant Eagle .Inc.
- 7.6.1 Company Overview
- 7.6.2 Key Executives
- 7.6.3 Company snapshot
- 7.6.4 Active Business Divisions
- 7.6.5 Product portfolio
- 7.6.6 Business performance
- 7.6.7 Major Strategic Initiatives and Developments
- 7.7 L Rowland & Co (Retail) Ltd
- 7.7.1 Company Overview
- 7.7.2 Key Executives
- 7.7.3 Company snapshot
- 7.7.4 Active Business Divisions
- 7.7.5 Product portfolio
- 7.7.6 Business performance
- 7.7.7 Major Strategic Initiatives and Developments
- 7.8 McKesson Corporation
- 7.8.1 Company Overview
- 7.8.2 Key Executives
- 7.8.3 Company snapshot
- 7.8.4 Active Business Divisions
- 7.8.5 Product portfolio
- 7.8.6 Business performance
- 7.8.7 Major Strategic Initiatives and Developments
- 7.9 Medlife
- 7.9.1 Company Overview
- 7.9.2 Key Executives
- 7.9.3 Company snapshot
- 7.9.4 Active Business Divisions
- 7.9.5 Product portfolio
- 7.9.6 Business performance
- 7.9.7 Major Strategic Initiatives and Developments
- 7.10 Netmeds Marketplace Ltd.
- 7.10.1 Company Overview
- 7.10.2 Key Executives
- 7.10.3 Company snapshot
- 7.10.4 Active Business Divisions
- 7.10.5 Product portfolio
- 7.10.6 Business performance
- 7.10.7 Major Strategic Initiatives and Developments
- 7.11 Optum. Inc.
- 7.11.1 Company Overview
- 7.11.2 Key Executives
- 7.11.3 Company snapshot
- 7.11.4 Active Business Divisions
- 7.11.5 Product portfolio
- 7.11.6 Business performance
- 7.11.7 Major Strategic Initiatives and Developments
- 7.12 SHOP-APOTHEKE EUROPE N.V.
- 7.12.1 Company Overview
- 7.12.2 Key Executives
- 7.12.3 Company snapshot
- 7.12.4 Active Business Divisions
- 7.12.5 Product portfolio
- 7.12.6 Business performance
- 7.12.7 Major Strategic Initiatives and Developments
- 7.13 T Easy Medico
- 7.13.1 Company Overview
- 7.13.2 Key Executives
- 7.13.3 Company snapshot
- 7.13.4 Active Business Divisions
- 7.13.5 Product portfolio
- 7.13.6 Business performance
- 7.13.7 Major Strategic Initiatives and Developments
- 7.14 The Kroger Co.
- 7.14.1 Company Overview
- 7.14.2 Key Executives
- 7.14.3 Company snapshot
- 7.14.4 Active Business Divisions
- 7.14.5 Product portfolio
- 7.14.6 Business performance
- 7.14.7 Major Strategic Initiatives and Developments
- 7.15 UK Meds Direct Ltd.
- 7.15.1 Company Overview
- 7.15.2 Key Executives
- 7.15.3 Company snapshot
- 7.15.4 Active Business Divisions
- 7.15.5 Product portfolio
- 7.15.6 Business performance
- 7.15.7 Major Strategic Initiatives and Developments
- 7.16 Walgreen Co.
- 7.16.1 Company Overview
- 7.16.2 Key Executives
- 7.16.3 Company snapshot
- 7.16.4 Active Business Divisions
- 7.16.5 Product portfolio
- 7.16.6 Business performance
- 7.16.7 Major Strategic Initiatives and Developments
- 7.17 Walgreens Boots Alliance. Inc.
- 7.17.1 Company Overview
- 7.17.2 Key Executives
- 7.17.3 Company snapshot
- 7.17.4 Active Business Divisions
- 7.17.5 Product portfolio
- 7.17.6 Business performance
- 7.17.7 Major Strategic Initiatives and Developments
- 7.18 Walmart
- 7.18.1 Company Overview
- 7.18.2 Key Executives
- 7.18.3 Company snapshot
- 7.18.4 Active Business Divisions
- 7.18.5 Product portfolio
- 7.18.6 Business performance
- 7.18.7 Major Strategic Initiatives and Developments
- 7.19 Zur Rose Group AG
- 7.19.1 Company Overview
- 7.19.2 Key Executives
- 7.19.3 Company snapshot
- 7.19.4 Active Business Divisions
- 7.19.5 Product portfolio
- 7.19.6 Business performance
- 7.19.7 Major Strategic Initiatives and Developments
8: Analyst Perspective and Conclusion
- 8.1 Concluding Recommendations and Analysis
- 8.2 Strategies for Market Potential
Scope of Report
Aspects | Details |
---|---|
By Type |
|
Report Licenses
$3200
$4500
$5500